# BloodLink Final QA Report

Status: IN PROGRESS — automated regression suites passed; UI and deployment
walkthroughs remain blocked or unrun.

## Executive summary

The repository inventory identifies 19 feature/security areas across
Individual, Hospital, Blood Centre, and Admin roles. Existing automated
regression suites passed 199 checks across API, web and mobile. No app services
or safe QA accounts were available, so no authenticated UI journeys or mobile
device flows have been claimed. Existing repository changes and Supabase were
not touched by this QA activity.

## Current counts

- Discovered feature areas: 19.
- Test entries logged: 13, including reconnaissance, automated suites, and
  environment-limited checks.
- Passed: 8; failed: 0; blocked: 4; not run: 1. One blocked API invocation was
  superseded by a successful rerun; these counts reflect final entry statuses,
  not product failures.
- Automated results: API 156/156, web 29/29, mobile 14/14; API TypeScript build
  passed. These results are not full user journey tests.
- Feature areas: 17 have partial automated evidence; 1 profile/eligibility
  management area is absent; 1 deployment/runtime area is not run. All 19
  still lack complete UI validation.
- Confirmed defects: 0; untested areas must not be treated as passing.

## Coverage by feature and role

See [test plan](COMPREHENSIVE_TEST_PLAN.md) for the full feature inventory and
role/workflow matrix. Automated tests cover portions of auth, routing, admin,
discovery, PatientNeed, BloodRequest, response/fulfillment, conversations,
subscriptions, notifications, mobile sessions and security boundaries.
Interactive journeys for Individual, Hospital, Blood Centre and Admin remain
blocked; mobile emulator/device coverage remains blocked.

## Security and usability

Automated security tests covered several authorization, ownership, state
transition, privacy projection and error-handling boundaries. No dynamic
cross-role UI or usability finding has been established; those checks require
safe local accounts and runnable UI infrastructure.

## Readiness and limitations

- Demonstration readiness: NOT READY TO DEMONSTRATE from this environment; no
  live UI is running and no cross-role journey was exercised.
- Deployment readiness: NOT ASSESSED by this QA pass; this task does not deploy.
- Environment limitation: no local listener/database/mobile runtime or test
  identities found; Supabase must not be used for exploratory writes.
- Confidence: medium for automated API/client behavior; low for whole-product
  behavior because UI/device and deployed journeys remain untested.

## Prioritized next steps

1. Provide a disposable local/test environment with migrations applied and
   non-personal accounts for Individual, Hospital, Blood Centre and Admin.
2. Start API and web locally and provide an emulator/device with the test API
   configured; then record complete UI workflows and persistence evidence.
3. Run deployment health checks only against a user-designated staging target.
4. Reconcile feature statuses, defects, counts and readiness after interactive
   coverage completes.
